Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Real world evaluation of Evusheld in prevention of COVID-19 in immunocompromised patients: An observational cohort study.
Journal: The American journal of the medical sciences
Published: July 18, 2025
Choroidal effusion: a rare and unusual complication of daratumumab.
Journal: BMJ case reports
Published: August 01, 2022
TdT Positive Lymphoma with MYC, BCL2 and BCL6 Rearrangements: A Review of Diagnosis and Treatment.
Journal: Mediterranean journal of hematology and infectious diseases
Published: September 28, 2021
More than an Incidentaloma: The Nonreportable NIPT.
Journal: Case reports in obstetrics and gynecology
Published: July 26, 2021
Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma.
Journal: British journal of haematology
Published: January 12, 2018
Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results.
Journal: British journal of haematology
Published: June 13, 2016
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 09, 2016
Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 24, 2016
Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 29, 2015
Last Updated: 09/26/2026